Literature DB >> 27058467

A Serious Adult Intraosseous Catheter Complication and Review of the Literature.

Yonatan Y Greenstein1, Seth J Koenig, Paul H Mayo, Mangala Narasimhan.   

Abstract

OBJECTIVE: Current guidelines recommend the use of intraosseous access when IV access is not readily attainable. The pediatric literature reports an excellent safety profile, whereas only small prospective studies exist in the adult literature. We report a case of vasopressor extravasation and threatened limb perfusion related to intraosseous access use and our management of the complication. We further report our subsequent systematic review of intraosseous access in the adult population. DATA SOURCES: Ovid Medline was searched from 1946 to January 2015. STUDY SELECTION: Articles pertaining to intraosseous access in the adult population (age greater than or equal to 14 years) were selected. Search terms were "infusion, intraosseous" (all subfields included), and intraosseous access" as key words. DATA EXTRACTION: One author conducted the initial literature review. All authors assessed the methodological quality of the studies and consensus was used to ensure studies met inclusion criteria. DATA SYNTHESIS: The case of vasopressor extravasation was successfully treated with pharmacologic interventions, which reversed the effects of the extravasated vasopressors: intraosseous phentolamine, topical nitroglycerin ointment, and intraarterial verapamil and nitroglycerin. Our systematic review of the adult literature found 2,332 instances of intraosseous insertion. A total of 2,106 intraosseous insertion attempts were made into either the tibia or the humerus; 192 were unsuccessful, with an overall success rate of 91%. Five insertions were associated with serious complications. A total of 226 insertion attempts were made into the sternum; 54 were unsuccessful, with an overall success rate of 76%.
CONCLUSIONS: Intraosseous catheter insertion provides a means for rapid delivery of medications to the vascular compartment with a favorable safety profile. Our systematic literature review of adult intraosseous access demonstrates an excellent safety profile with serious complications occurring in 0.3% of attempts. We report an event of vasopressor extravasation that was potentially limb threatening. Therapy included local treatment and injection of intraarterial vasodilators. Intraosseous access complications should continue to be reported, so that the medical community will be better equipped to treat them as they arise.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27058467     DOI: 10.1097/CCM.0000000000001714

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  5 in total

1.  Noninvasive analysis and identification of an intramuscular fluid collection by postmortem 1H-MRS in a case of a fatal motor vehicle accident.

Authors:  Jakob Heimer; Dominic Gascho; Carlo Tappero; Michael J Thali; Niklaus Zoelch
Journal:  Int J Legal Med       Date:  2019-11-12       Impact factor: 2.686

2.  Bent Metal in a Bone: A Rare Complication of an Emergent Procedure or a Deficiency in Skill Set?

Authors:  Mridula Krishnan; Katherine Lester; Amber Johnson; Kaye Bardeloza; Peter Edemekong; Ilya Berim
Journal:  Case Rep Crit Care       Date:  2016-11-27

3.  Deltoid Compartment Syndrome: A Rare Complication after Humeral Intraosseous Access.

Authors:  Kishan M Thadikonda; Francesco M Egro; Irene Ma; Alexander M Spiess
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-01-24

4.  FascIOtomy: Ultrasound Evaluation of an Intraosseous Needle Causing Compartment Syndrome.

Authors:  Tiffany M Abramson; Laith Alreshaid; Tarina Kang; Thomas Mailhot; Talib Omer
Journal:  Clin Pract Cases Emerg Med       Date:  2018-09-05

5.  Intramuscular hemorrhage and fluid extravasation into the anterior compartment secondary to intraosseous resuscitation, the "Nicked-Cortex" sign.

Authors:  Paul Wasserman; Chandana Kurra; Kristin Taylor; Jaime R Fields; Miracle Caldwell
Journal:  Radiol Case Rep       Date:  2019-10-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.